Sinopharm Capital
Asia, Shanghai, China, Shanghai'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
Description
Sinopharm Capital is a private equity arm of China National Pharmaceutical Group Corporation.
Investor Profile
Sinopharm Capital has backed more than 6 startups, with 0 new investments in the last 12 months alone. The firm has led 2 rounds, about 33% of its total and boasts 9 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series C, Series A rounds (top funding stages).
- Majority of deals are located in United States, China.
- Strong thematic focus on Health Care, Medical, Biotechnology.
Stage Focus
- Series B (67%)
- Series C (17%)
- Series A (17%)
Country Focus
- United States (50%)
- China (50%)
Industry Focus
- Health Care
- Medical
- Biotechnology
- Medical Device
- Robotics
- Clinical Trials
- Therapeutics
- Artificial Intelligence (Ai)
- Big Data
- Cloud Computing
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Sinopharm Capital frequently co-invest with?
'/%3e%3cuse xlink:href='%23a' transform='rotate(144 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(216 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(288 450 300)'/%3e%3c/svg%3e)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
What are some of recent deals done by Sinopharm Capital?
Find More Investors Like Sinopharm Capital
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides
